awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q41610309-172E2FE0-AD78-4731-A356-299B57150710
Q41610309-172E2FE0-AD78-4731-A356-299B57150710
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41610309-172E2FE0-AD78-4731-A356-299B57150710
Single dose methodology to assess the influence of an alpha1-adrenoceptor antagonist on uroflowmetric parameters in patients with benign prostatic hyperplasia.
P2860
Q41610309-172E2FE0-AD78-4731-A356-299B57150710
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41610309-172E2FE0-AD78-4731-A356-299B57150710
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e1beb32710c5bac3e194591480d430d674d9b82c
P2860
Terazosin in the treatment of benign prostatic hyperplasia: a multicentre, placebo-controlled trial.